Application of the GRAPPA psoriatic arthritis treatment recommendations in clinical practice.
Affiliation
Bone and Joint Unit, Dublin Academic Health Care, St Vincent's University, Hospital, Elm Park, Dublin 4, Ireland.Issue Date
2012-02-01T10:33:17ZMeSH
Arthritis, Psoriatic/*therapyClinical Protocols
Humans
Severity of Illness Index
Metadata
Show full item recordCitation
Curr Rheumatol Rep. 2010 Aug;12(4):264-71.Journal
Current rheumatology reportsDOI
10.1007/s11926-010-0109-yPubMed ID
20440659Abstract
Psoriatic disease presents with a complex array of clinical features, including peripheral synovitis and skin psoriasis, but there is also variable involvement of the nail, dactylitis, enthesitis, and spinal disease. Composite assessment of disease activity and response taking into account the impact of the disease as a whole on an individual's health and quality of life is of vital importance. Following an extensive literature review, discussions, and consensus, the Group for Research in Psoriasis and Psoriatic Arthritis (GRAPPA) published guidelines to help clinicians make treatment decisions. The utility of these guidelines in routine clinical practice is further enhanced by incorporating them into a Composite Psoriatic Disease Activity Index (CPDAI). The potential application of the CPDAI in typical psoriatic disease patients is presented and discussed. Validation and possible modification of a composite disease activity and responder index is currently being undertaken by GRAPPA.Language
engISSN
1534-6307 (Electronic)1523-3774 (Linking)
ae974a485f413a2113503eed53cd6c53
10.1007/s11926-010-0109-y
Scopus Count
Collections
Related articles
- Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter Study.
- Authors: Tillett W, FitzGerald O, Coates LC, Packham J, Jadon DR, Massarotti M, Brook M, Lane S, Creamer P, Antony A, Korendowych E, Rambojun A, McHugh NJ, Helliwell PS, PROMPT Study Group
- Issue date: 2021 Jun
- GRAPPA treatment recommendations: an update from the GRAPPA 2013 Annual Meeting.
- Authors: Coates LC, Ritchlin CT, Kavanaugh AF
- Issue date: 2014 Jun
- Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group.
- Authors: Leung YY, Tillett W, de Wit M, Orbai AM, Coates LC, FitzGerald O, Helliwell PS, Strand V, Mease PJ, Goel N, Christensen R, Merola JF, Lindsay CA, Ogdie A, Gossec L, Gladman DD
- Issue date: 2023 Nov
- Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter Study.
- Authors: Tillett W, FitzGerald O, Coates LC, Packham J, Jadon DR, Massarotti M, Brook M, Lane S, Creamer P, Antony A, Korendowych E, Rambojun A, McHugh NJ, Helliwell PS, PROMPT Study Group
- Issue date: 2021 Jun